Anke Biotechnology: sole distributor of loratadine oral solution

date
09/07/2026
Anke Biotechnology announced that the company and its wholly-owned subsidiary Anhui Huasheng have reached a strategic cooperation with Hefei Yigong and its wholly-owned subsidiary Enrite, and signed the "National Total Distribution Agreement for Loratadine Oral Solution". Enrite authorizes Anhui Huasheng as the national sole general distributor for the cooperative product Loratadine Oral Solution, fully responsible for market promotion and sales work. The cooperation period is from the effective date of the agreement to December 31, 2042. The product has obtained the drug registration certificate from the National Medical Products Administration, with indications covering the relief of symptoms of children's seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria.